OTLC Oncotelic Therapeutics, Inc.

Fundamentals / CIK 0000908259 / USD

Oncotelic Therapeutics, Inc. reported $393.8M in total assets and net income of $247.5M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open OTLC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$247.2M$123.6M$0-$34.10MFY 2016 Net Income: -$13.65M2016FY 2017 Net Income: -$13.81M2017FY 2018 Net Income: -$713K2018FY 2019 Net Income: -$6.64M2019FY 2020 Revenue: $1.74MFY 2020 Net Income: -$9.50M2020FY 2021 Net Income: -$9.39M2021FY 2022 Net Income: $5.09M2022FY 2023 Revenue: $70KFY 2023 Net Income: -$7.90M2023FY 2024 Net Income: -$4.52M2024FY 2025 Net Income: $249.3M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- $70K -- -- $1.74M -- -- -- --
Research & Development $4.4K -- $61K $757K $3.66M $4.30M $1.37M $650K $10.47M $8.76M
Total Operating Expenses $3.19M $3.58M $6.72M $9.72M $9.13M $9.33M $4.31M $713K $13.84M $13.76M
Operating Income -$3.19M -$3.58M -$6.65M -$9.72M -$9.13M -$7.58M -$4.31M -$713K -$13.84M -$13.76M
EBITDA -- -- -- -- -$9.06M -$7.22M -$4.25M -$677K -$13.83M -$13.74M
Interest Income -- -- -- -- -- -- $123 $16K $35K $106K
Interest Expense -- -- $1.04M $2.97M $2.00M $2.00M $749K -- -- --
Income Before Tax $360.6M -$4.78M -- -- -- -- -- -- -- --
Income Tax Expense $111.5M -- -- -- -- -- -- -- -- --
Net Income $249.3M -$4.52M -$7.90M $5.09M -$9.39M -$9.50M -$6.64M -$713K -$13.81M -$13.65M
Basic EPS $0.59 $0.01 -$0.02 $0.01 -$0.03 -$0.11 -$0.11 -$0.12 -$0.52 -$0.51
Diluted EPS $0.59 -$0.01 -$0.02 $0.01 -$0.03 -$0.11 -$0.11 -$0.12 -$0.52 -$0.51
Basic Shares Outstanding 421.0M 404.4M 384.1M 384.1M 303.1M 88.1M 60.0M 6.1M 26.5M 26.5M
Diluted Shares Outstanding 422.2M 404.4M 396.2M 457.3M 303.1M 88.1M 60.0M 6.1M 26.5M 26.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- $250K -- -- -- -- -- --
Research & Development $1.6K $345 $795 $3.3K $426 $297 $297 --
Total Operating Expenses $233K $1.09M $1.85M $2.53M $491K $66K $101K $31K
Operating Income -$233K -$844K -$1.85M -$2.53M -$491K -$66K -$101K -$31K
Interest Expense $287K $318K -- -- $231K $208K -- --
Net Income -$1.11M $388K -$2.19M $250.4M -$1.05M $278K -$299K -$601K
Basic EPS $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00 --
Diluted EPS $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00 --
Basic Shares Outstanding 457.2M 447.4M 443.8M -- 426.4M 408.3M 407.4M --
Diluted Shares Outstanding 457.2M 467.9M 443.8M -- 426.4M 452.8M 407.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $89K $86K $170K $241K $569K $474K $82K $2.5K $1.11M $3.54M
Short-Term Investments -- -- -- -- -- -- -- -- -- $8.51M
Cash & Short-Term Investments $89K $86K $170K $241K $569K $474K $82K $2.5K $1.11M $12.00M
Accounts Receivable, Net $51K $19K $19K $20K $20K $20K $150K -- -- --
Total Current Assets $1.20M $134K $272K $303K $627K $616K $273K $2.5K $1.14M $14.07M
Property, Plant & Equipment, Net -- -- -- -- -- -- $48K -- $2.0K $11K
Goodwill $2.79M $2.79M $5.99M $12.07M $21.06M $21.06M $21.06M -- -- --
Intangible Assets -- -- -- -- $822K $873K $925K $976K -- --
Long-Term Investments -- -- -- -- -- -- -- $1.77M -- --
Other Non-Current Assets -- -- -- -- -- -- -- -- $33K $33K
Total Non-Current Assets $391.9M $26.54M $29.74M $35.81M $22.99M $23.05M $23.41M $2.75M $35K $44K
Total Assets $393.1M $26.68M $30.01M $36.12M $23.61M $23.66M $23.68M $2.75M $1.17M $14.11M
Accounts Payable $1.64M $1.69M $1.66M $332K $1.93M $1.94M $1.79M $915K $788K $310K
Short-Term Debt -- $2.42M $1.77M $390K $359K $95K -- -- -- --
Total Current Liabilities $18.14M $19.20M $16.50M $16.92M $15.45M $11.18M $6.78M $283K $1.65M $1.61M
Total Non-Current Liabilities $113.2M $0 $1.90M $0 $0 $0 $0 $0 $6.6K $0
Total Liabilities $131.4M $19.20M $18.40M $16.92M $15.45M $11.18M $6.78M $283K $1.66M $1.61M
Total Debt (incl. Leases) -- $2.42M $1.77M $390K $359K $95K -- -- -- --
Common Stock $4.43M $4.07M $3.99M $3.92M $3.75M $906K $841K $68K $265K $265K
Retained Earnings $211.2M -$38.04M -$33.52M -$25.93M -$31.02M -$21.63M -$12.13M -$5.49M -$292.3M -$278.5M
Total Stockholders' Equity $262.8M $8.25M $12.13M $19.41M $7.96M $11.77M $16.90M $2.46M -$484K $12.50M
Total Equity $261.7M $7.48M $11.61M $19.19M $8.16M $12.48M $16.90M $2.46M -$484K $12.50M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $64K $186K $64K $89K $409K $88K $79K $86K
Cash & Short-Term Investments $64K $186K $64K $89K $409K $88K $79K $86K
Accounts Receivable, Net $2.1K $2.1K $2.1K $51K $4.0K $19K $19K $19K
Total Current Assets $1.27M $1.46M $2.07M $1.20M $1.61M $138K $125K $134K
Goodwill $2.79M $2.79M $2.79M $2.79M $2.79M $2.79M $2.79M $2.79M
Total Non-Current Assets $392.5M $393.3M $391.9M $391.9M $26.54M $26.54M $26.54M $26.54M
Total Assets $393.8M $394.8M $394.0M $393.1M $28.16M $26.68M $26.67M $26.68M
Accounts Payable $1.73M $1.83M $1.70M $1.64M $1.69M $1.71M $1.69M $1.69M
Short-Term Debt -- -- -- -- -- $2.72M $2.58M $2.42M
Total Current Liabilities $18.04M $17.91M $18.40M $18.14M $20.08M $19.29M $19.48M $19.20M
Total Non-Current Liabilities $113.5M $113.4M $113.3M $113.2M $0 $0 $0 $0
Total Liabilities $131.5M $131.3M $131.7M $131.4M $20.08M $19.29M $19.48M $19.20M
Total Debt (incl. Leases) -- -- -- -- -- $2.72M $2.58M $2.42M
Common Stock $4.58M $4.57M $4.44M $4.43M $4.39M $4.08M $4.08M $4.07M
Retained Earnings $208.3M $209.4M $209.0M $211.2M -$39.11M -$38.06M -$38.34M -$38.04M
Total Stockholders' Equity $263.5M $264.6M $263.3M $262.8M $9.05M $8.30M $8.02M $8.25M
Total Equity $262.3M $263.4M $262.2M $261.7M $8.08M $7.39M $7.18M $7.48M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $249.0M -$4.78M -$8.21M $4.68M -$10.52M -$9.97M -$6.64M -$2.74M -$13.81M -$13.65M
Depreciation & Amortization -- -- -- -- $62K $364K $61K $36K $9.0K $19K
Stock-Based Compensation $2.38M $0 $0 $902K $763K $2.15M $341K $80K $835K $804K
Operating Cash Flow -$1.38M -$740K -$1.32M -$1.45M -$4.43M -$2.81M -$2.28M -$241K -$10.93M -$15.24M
Investing Cash Flow -- -- -- -- -- -- $189K -- $8.51M -$8.51M
Common Stock Issued -- -- -- $159K $420K -- $83K $240K -- --
Financing Cash Flow $1.39M $656K $1.25M $1.13M $4.53M $3.22M $2.17M $240K -- --
Net Change in Cash $2.7K -$84K -$71K -$327K $95K $412K $79K -$980 -$2.42M -$23.75M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$1.16M $341K -$2.24M $250.3M -$1.11M $210K -$364K -$654K
Stock-Based Compensation $63K $730K $1.64M $0 $0 $0 $0 $0
Change in Receivables $0 $0 $49K -- -- -- -- --
Operating Cash Flow -$342K -$92K -$342K -$783K -$307K -$126K -$167K -$104K
Common Stock Issued $6.6K $6.6K -- -- -- -- -- --
Financing Cash Flow $220K $215K $317K $463K $628K $135K $160K $41K
Net Change in Cash -$122K $122K -$25K -$320K $321K $8.8K -$7.0K -$63K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -9497.2% -- -- -435.7% -- -- -- --
Net Profit Margin -- -- -11290.1% -- -- -545.9% -- -- -- --
Return on Equity (ROE) 94.9% -54.8% -65.2% 26.3% -118.0% -80.7% -39.3% -28.9% -- -109.2%
Return on Assets (ROA) 63.4% -17.0% -26.3% 14.1% -39.8% -40.2% -28.0% -25.9% -1178.5% -96.7%
Current Ratio 0.07x 0.01x 0.02x 0.02x 0.04x 0.06x 0.04x 0.01x 0.69x 8.72x
Quick Ratio 0.01x 0.01x 0.01x 0.02x 0.04x 0.04x 0.03x 0.01x 0.68x 7.43x
Debt to Equity -- 0.29x 0.15x 0.02x 0.05x 0.01x -- -- -- --
Net Income Growth (YoY) -- -- -255.1% -- -- -- -- -- -- --
EPS Growth (YoY) +5800.0% -- -300.0% -- -- -- -- -- -- --
10Y Revenue / Share Growth -- -- -99.5% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) 93.9% 93.6% 94.0% 94.9% -18.4% -47.3% -55.0% -54.8%
Return on Assets (ROA) 62.8% 62.7% 62.8% 63.4% -5.9% -14.7% -16.6% -17.0%
Current Ratio 0.07x 0.08x 0.11x 0.07x 0.08x 0.01x 0.01x 0.01x
Quick Ratio 0.00x 0.01x 0.00x 0.01x 0.02x 0.01x 0.01x 0.01x
Debt to Equity -- -- -- -- -- 0.33x 0.32x 0.29x
Net Income Growth (YoY) -- +39.7% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0000908259) · from December 31, 2009 Data through September 30, 2026 · synced Nov 21, 2026, 05:09 UTC · Open in terminal